With regard to a possible class action lawsuit inv
Post# of 155256
(Total Views: 378)
Posted On: 07/18/2025 11:35:40 AM
With regard to a possible class action lawsuit involving Feuerstein and CYDY, the excerpts below are from page 18 of CYDY’s 10-Q for the quarter ending 2/28/25.
The 6/24/22 complaint mentions Feuerstein a few times such as this:
https://ktmc.com/webfiles/2022-06-24%200104%2...20C....pdf
CYDY, Kelly, Mulholland, and Pourhassan filed for dismissal, but a judge ruled on 6/25/25 that the claims are plausible and denied the motion to dismiss.
The link below goes to a 6/27/25 Fierce Biotech article which discusses this. If you want to read the judge’s 41-page ruling, click the link in the 3rd paragraph of that article.
https://www.fiercebiotech.com/biotech/cytodyn...hatgpt.com
There may be a stockholder lawsuit against Feuerstein, but I have not seen anything about that. It is possible that some have confused the class action lawsuit which quoted Feuerstein.
It is important to note that the 6/25/25 ruling did not find CYDY guilty. The judge just ruled that the lawsuit can proceed.
Riztheinvestor, I hope you are going after Feuerstein in addition to the others. I would like to know who paid him for the hit pieces.
Quote:
On March 17, 2021, a stockholder filed a putative class-action lawsuit (the “March 17, 2021 lawsuit”) in the U.S. District Court for the Western District of Washington against the Company and certain former officers. The complaint generally alleges the defendants made false and misleading statements regarding the viability of leronlimab as a potential treatment for COVID-19. On April 9, 2021, a second stockholder filed a similar putative class action lawsuit in the same court, which the plaintiff voluntarily dismissed without prejudice on July 23, 2021. On August 9, 2021, the court appointed lead plaintiffs for the March 17, 2021 lawsuit. On December 21, 2021, lead plaintiffs filed an amended complaint, which is brought on behalf of an alleged class of those who purchased the Company’s common stock between March 27, 2020 and May 17, 2021. The amended complaint generally alleges that the defendants violated Sections 10(b) and/or 20(a) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) and Rule 10b-5 promulgated thereunder by making purportedly false or misleading statements concerning, among other things, the safety and efficacy of leronlimab as a potential treatment for COVID-19, the Company’s CD10 and CD12 clinical trials, and its human immunodeficiency virus (“HIV”) Biologic License Application (“BLA”).
On February 25, 2022, the defendants filed a motion to dismiss the amended complaint. On June 24, 2022, lead plaintiffs filed a second amended complaint. The second amended complaint is brought on behalf of an alleged class of those who purchased the Company’s common stock between March 27, 2020 and March 30, 2022
All defendants have filed motions to dismiss the second amended complaint in whole or in part. The Company and the individual defendants deny all allegations of wrongdoing in the complaint and intend to vigorously defend the matter.
The 6/24/22 complaint mentions Feuerstein a few times such as this:
Quote:
For example, on July 13, 2020, Adam Feuerstein of STAT+ issued an article entitled “FDA refuses application for HIV drug from CytoDyn, raising more questions about its credibility,” which described the receipt of the RTF letter as “a setback that could delay a decision [on leronlimab] for months, if not years”
https://ktmc.com/webfiles/2022-06-24%200104%2...20C....pdf
CYDY, Kelly, Mulholland, and Pourhassan filed for dismissal, but a judge ruled on 6/25/25 that the claims are plausible and denied the motion to dismiss.
The link below goes to a 6/27/25 Fierce Biotech article which discusses this. If you want to read the judge’s 41-page ruling, click the link in the 3rd paragraph of that article.
https://www.fiercebiotech.com/biotech/cytodyn...hatgpt.com
There may be a stockholder lawsuit against Feuerstein, but I have not seen anything about that. It is possible that some have confused the class action lawsuit which quoted Feuerstein.
It is important to note that the 6/25/25 ruling did not find CYDY guilty. The judge just ruled that the lawsuit can proceed.
Riztheinvestor, I hope you are going after Feuerstein in addition to the others. I would like to know who paid him for the hit pieces.
(14)
(0)